Insider Buying: Nova Leap Health Corp. (CVE:NLH) Director Purchases C$15,000.00 in Stock

Nova Leap Health Corp. (CVE:NLH) Director Christopher Donald Dobbin bought 50,000 shares of the company’s stock in a transaction on Friday, May 24th. The shares were bought at an average cost of C$0.30 per share, for a total transaction of C$15,000.00.

Christopher Donald Dobbin also recently made the following trade(s):

• On Wednesday, May 22nd, Christopher Donald Dobbin bought 15,000 shares of Nova Leap Health stock. The shares were bought at an average cost of C$0.35 per share, for a total transaction of C$5,182.50.

Nova Leap Health Stock Down 10.4 %

Shares of CVE NLH opened at C$0.30 on Monday. The company has a current ratio of 1.78, a quick ratio of 1.13 and a debt-to-equity ratio of 6.84. The stock has a market capitalization of C$25.86 million, a PE ratio of -15.00 and a beta of 1.53. The stock’s fifty day simple moving average is C$0.26 and its two-hundred day simple moving average is C$0.24. Nova Leap Health Corp. has a 12-month low of C$0.13 and a 12-month high of C$0.38.

Nova Leap Health (CVE:NLH) last issued its quarterly earnings data on Thursday, March 7th. The company reported C($0.01) EPS for the quarter. Nova Leap Health had a negative net margin of 1.09% and a negative return on equity of 1.55%. The business had revenue of C$8.92 million for the quarter, compared to analysts’ expectations of C$11.17 million. As a group, analysts expect that Nova Leap Health Corp. will post 0.0136799 EPS for the current fiscal year.

About Nova Leap Health

Nova Leap Health Corp., together with its subsidiaries, provides home and home health care services in the United States and Canada. Its services include dementia care, companionship, personal and skilled nursing care, respite care, cooking and meal preparation, bathing, dressing, grooming, housekeeping, errands, transportation, and medication reminders.